Sandbox:Mitra3: Difference between revisions

Revision as of 17:42, 3 August 2020

Therapuetic Considerations in RVMI

Reperfusion

Maintenance of RV preload

Decreased RV afterload

Restoring Rate/Rhythm and AV synchrony

Inotropic support

Mechanical Circulatory Support

{{{ ! }}}

• Thrmobolysis
• Percutaneous coronary intervention<be>

• Avoidance of preload reducing agents, such as:

• Systemic or pulmonary vasodilators:
*Inhaled nitric oxide

• In patients with bradyarrhthmias:
Atropine Pacemaker

In patients with refractory hypotension

May be needed in patients with cardiogenic shock secondary to RVMI

@@ Line 6: / Line 6: @@
 {{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 | |B01=Reperfusion|B02=Maintenance of RV preload|B03=Decreased RV afterload|B04=Restoring Rate/Rhythm and AV synchrony|B05=Inotropic support|B06=Mechanical Circulatory Support}}
 {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | ! | | | | |!| | |}}
-{{familytree |boxstyle=text-align: left; | | | C01 | | C02 | | C03| |C05| |C06| |C01=• Thrmobolysis<br>• Percutaneous coronary intervention<be>
+{{familytree |boxstyle=text-align: left; | | | C01 | | C02 | | C03| |C04| |C05| |C06| | C01=• Thrmobolysis<br>• Percutaneous coronary intervention<be>
 |C02= • Avoidance of preload reducing agents, such as:<br>
 *Nitrates
 *Diuretics
-*Morphin|C03=• Systemic or pulmonary vasodilators:<br> *Inhaled nitric oxide<br>
+*Morphin|C03=• Systemic or pulmonary vasodilators:<br> *Inhaled nitric oxide<br>|C04=• In patients with bradyarrhthmias:<br> Atropine Pacemaker|C05=In patients with refractory hypotension|C06= May be needed in patients with cardiogenic shock secondary to RVMI}}
-|C04=• In patients with bradyarrhthmias:<br> Atropine Pacemaker|C05=Inotropic support |C06= May be needed in patients with cardiogenic shock secondary to RVMI}}
 {{familytree | | | | | | | | | | | |!| | | |!| }}
 {{familytree/end}}